OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
April 20, 2016
Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.
April 18, 2016
Linker technology and drug combinations play an important role in the efficacy of ADCs.
April 14, 2016
The Office of Generic Drugs highlights the agency’s work to advance generic drugs.
April 12, 2016
FDA approved an update in the manufacturing of Prezista (darunavir) using a continuous manufacturing line at Janssen Supply Chain’s facility in Puerto Rico.
April 06, 2016
The agency has announced the creation of the Combination Products Policy Council to address issues related to combination products.
April 04, 2016
Texture analyzers can be used to evaluate wall hardness and elasticity of softgel capsules.
Consider the 3 Ps (product, process, and patient) when choosing a parenteral packaging material.
Even though the organizers of New York’s Tribeca Film Festival decided not to air the anti-vaccine film by discredited British researcher Andrew Wakefield, the so-called documentary is getting a healthy run and further perpetuating the myth of a link between childhood vaccination and autism.
April 02, 2016
Industry experts and FDA’s Office of Pharmaceutical Quality discuss the challenges, trends, and regulations involved in ensuring quality in solid and semi-solid dosage forms.
Pharmaceutical Technology spoke with Bill Randolph, vice-president, Technical Services, Janssen Supply Chain, about some of the considerations for technology transfer of a continuous, solid-dosage manufacturing process and what he sees as the outlook for continuous manufacturing.